0.000USD0.000åå ŽååŒÂ 07/24, 09:30 (ET)
53.19BæäŸ¡ç·é¡
43.89çŽè¿12ã¶æPER
Takeda Pharmaceutical Co Ltd
äž»èŠããŒã¿
16.745å§å€
16.845é«å€
3.51Måºæ¥é«
43.89çŽè¿12ã¶æPER
11.07äºæ³PER
0.994çŽè¿12ã¶æé
åœ
0.11%売買å転ç
16.870忥çµå€
16.685å®å€
28.62M売買代é
0.49æ ªäŸ¡åçç
1.13PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
5.91%çŽè¿12ã¶æé
åœå©åã
1.29%ç·è³ç£å©çç
18.89552é±é«å€
0.70åºæ¥é«æ¯ç%
107.93BçŽå©ç
3.16Bæ ªåŒæ°
0.38361æ ªåœããå©çïŒEPSïŒ
-0.04ããŒã¿å€
2.61%èªå·±è³æ¬å©çç
12.99052é±å®å€
0.95%æ¯ãå¹
48.79%ç²å©çç
53.19BæäŸ¡ç·é¡
9.07ãªã¹ã¯ãªã¿ãŒã³
0.81%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-23 äž»èŠã€ã³ãµã€ã
Takeda Pharmaceutical Co Ltdã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå®å®ã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»è¬åæ¥çã§ã®é äœã¯155äž58äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯21.13ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯å®å®æšç§»ãšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯è¯å¥œã§ããã¡ã³ãã¡ã³ã¿ã«ãºãåªããŠããŸãããããã¯ãã«ã«ã¯çŸåšã®ãã¬ã³ããè£ä»ãããã®ã§ã¯ãããŸãããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Takeda Pharmaceutical Co Ltdã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Takeda Pharmaceutical Co Ltdã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Takeda Pharmaceutical Co Ltd ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Takeda Pharmaceutical Co Ltd
TAK
3
ææšî
ææš
売ã(2)
äžç«(3)
è²·ã(2)
ç§»åå¹³å
売ã(2)
äžç«(0)
è²·ã(4)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Takeda Pharmaceutical Co Ltdã®äŒæ¥æ
å ±î
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
äŒæ¥ã³ãŒãTAK
äŒæ¥åTakeda Pharmaceutical Co Ltd
æé«çµå¶è²¬ä»»è
ãCEOãWeber (Christophe)
ãŠã§ããµã€ãhttps://www.takeda.com/
æ ªäž»çµ±èšî
ãããã質å
Takeda Pharmaceutical Co LtdïŒTAKïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îTakeda Pharmaceutical Co LtdïŒTAKïŒã®çŸåšã®æ ªäŸ¡ã¯16.84ã§ãã
Takeda Pharmaceutical Co Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îTakeda Pharmaceutical Co Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯TAKã§ãã
Takeda Pharmaceutical Co Ltdã®52é±é«å€ã¯ãããã§ããïŒ
îTakeda Pharmaceutical Co Ltdã®52é±é«å€ã¯18.89ã§ãã
Takeda Pharmaceutical Co Ltdã®52é±å®å€ã¯ãããã§ããïŒ
îTakeda Pharmaceutical Co Ltdã®52é±å®å€ã¯12.99ã§ãã
Takeda Pharmaceutical Co Ltdã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îTakeda Pharmaceutical Co Ltdã®æäŸ¡ç·é¡ã¯53.19Bã§ãã
Takeda Pharmaceutical Co Ltd (TAK) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãTakeda Pharmaceutical Co LtdïŒTAKïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯21.13ã§ãã
Takeda Pharmaceutical Co Ltd (TAK) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îTakeda Pharmaceutical Co LtdïŒTAKïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-0.30ã§ãã